PerkinElmer to Host International Summit on Newborn Screening
Virtual event will convene a global audience to explore new approaches and novel technologies used to help newborns get a healthier start to life
WHAT: PerkinElmer Inc., a global leader committed to innovating for a heathier world, will host a three-day scientific event exploring the latest advances in newborn screening programs and related technologies. Organized around the theme of “Learn, Share and Develop,” PerkinElmer’s Newborn Screening World View summit will feature more than 20 presentations from participants across 11 countries. Each day, presentations and Q&A sessions scheduled will focus on a different topic, which will include:
- Newborn screening around the world – discussions around new and expanding programs worldwide, and novel ways to overcome common challenges.
- Leading the newborn screening conversation – expert advice on optimizing workflow efficiencies, throughput and accuracy, as well as opportunities to expand newborn screening panels.
- The future of newborn screening – conversations around next generation sequencing, molecular screening and expanding screening techniques and ideas.
Registered attendees will have the opportunity to watch sessions in real-time or on-demand following the event.
WHEN: Tuesday, June 28 – Thursday, June 30, 2022
WHERE: This event is virtual. Register to attend at the link here.
WHY: It’s estimated that only one in every three newborns receives any form of newborn screening, and that many of those babies are screened for just one or two disorders. Even seemingly healthy newborns may not show signs or symptoms of a rare disease or genetic disorder until later in their development. Newborn screening programs are critical in that they help detect potentially life-threatening conditions early on and initiate timely medical interventions or treatments to ensure better health outcomes for the child.
As the global leader in newborn screening, PerkinElmer has organized this virtual summit to raise awareness of the critical importance of neonatal screening and create a platform for those involved in these efforts to share their success stories and best practices.
MORE: The PerkinElmer World View summit coincides with International Neonatal Screening Day (June 28), an annual observance and celebration of the advances and success of newborn screening programs worldwide. Featured speakers at PerkinElmer World View will include Professor Jim Bonham, president of the International Society for Neonatal Screening (ISNS); Dr. David Bick, clinical advisor for the Newborn Genomes Programme of Genomics England; as well as Andrew Zapfel and Dr. Lulu Chirande of the Consortium for Newborn Screening in Africa (CONSA).
To learn more about the summit, view the full agenda or register to attend, visit the webpage here.
PerkinElmer is a leading, global provider of end-to-end solutions that help scientists, researchers and clinicians better diagnose disease, discover new and more personalized drugs, monitor the safety and quality of our food, and drive environmental and applied analysis excellence. With an 85-year legacy of advancing science and a mission of innovating for a healthier world, our dedicated team of more than 16,000 collaborates closely with commercial, government, academic and healthcare customers to deliver reagents, assays, instruments, automation, informatics and strategic services that accelerate workflows, deliver actionable insights and support improved decision making. We are also deeply committed to good corporate citizenship through our dynamic ESG and sustainability programs. The Company reported revenues of approximately $5 billion in 2021, serves customers in 190 countries, and is a component of the S&P 500 index. Additional information is available at www.perkinelmer.com. Follow PerkinElmer on LinkedIn, Twitter, Facebook, Instagram, and YouTube.